These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1159 related articles for article (PubMed ID: 26166322)

  • 21. In vitro Activity of Sitafloxacin and Other Antibiotics against Bacterial Isolates from HRH Princess Maha Chakri Sirindhorn Medical Center, Srinakharinwirot University and Samitivej Sukhumvit Hospital.
    Tantisiriwat W; Linasmita P
    J Med Assoc Thai; 2017 Apr; 100(4):469-78. PubMed ID: 29912484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.
    Dowzicky MJ; Park CH
    Clin Ther; 2008 Nov; 30(11):2040-50. PubMed ID: 19108792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro susceptibilities to levofloxacin and various antibacterial agents of 12,866 clinical isolates obtained from 72 centers in 2010].
    Yamaguchi K; Ohno A; Ishii Y; Tateda K; Iwata M;
    Jpn J Antibiot; 2012 Jun; 65(3):181-206. PubMed ID: 23173294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection.
    Farrell DJ; Morrissey I; De Rubeis D; Robbins M; Felmingham D
    J Infect; 2003 Feb; 46(2):94-100. PubMed ID: 12634070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survey of the susceptibility of urinary isolates to antibacterial agents in 2003.
    Ishikawa K; Hayakawa S; Miyakawa S; Kusaka M; Shiroki R; Hoshinaga K
    J Infect Chemother; 2005 Feb; 11(1):44-7. PubMed ID: 15729488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative studies on activities on antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2000). III. Secular changes in susceptibility].
    Kumamoto Y; Tsukamoto T; Hirose T; Matsukawa M; Takahashi S; Kunishima Y; Fujime M; Fujita K; Ogihara M; Ishibashi K; Igari J; Shigeta S; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Yoshida H; Imafuku Y; Murai M; Ooe H; Nishikawa M; Watanabe K; Kobayashi Y; Uchida H; Oka T; Kitamura M; Takano Y; Matsuoka Y; Matsuda S; Sato S; Furuhama T; Kumon H; Monden K; Kohno S; Miyazaki Y; Tomono K; Aoki S; Mochida C; Hirakata Y
    Jpn J Antibiot; 2002 Oct; 55(5):568-655. PubMed ID: 12532638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy in 2007: general view of the pathogens' antibacterial susceptibility.
    Niki Y; Hanaki H; Matsumoto T; Yagisawa M; Kohno S; Aoki N; Watanabe A; Sato J; Hattori R; Terada M; Koashi N; Kozuki T; Maruo A; Morita K; Ogasawara K; Takahashi Y; Watanabe J; Takeuchi K; Fujimura S; Takeda H; Ikeda H; Sato N; Niitsuma K; Saito M; Koshiba S; Kaneko M; Miki M; Nakanowatari S; Honda Y; Chiba J; Takahashi H; Utagawa M; Kondo T; Kawana A; Konosaki H; Aoki Y; Ueda H; Sugiura H; Ichioka M; Goto H; Kurai D; Okazaki M; Yoshida K; Yoshida T; Tanabe Y; Kobayashi S; Okada M; Tsukada H; Imai Y; Honma Y; Nishikawa K; Yamamoto T; Kawai A; Kashiwabara T; Takesue Y; Wada Y; Nakajima K; Miyara T; Toda H; Mitsuno N; Sugimura H; Yoshioka S; Kurokawa M; Munekawa Y; Nakajima H; Kubo S; Ohta Y; Mikasa K; Maeda K; Kasahara K; Koizumi A; Sano R; Yagi S; Takaya M; Kurokawa Y; Kusano N; Mihara E; Kuwabara M; Fujiue Y; Ishimaru T; Matsubara N; Kawasaki Y; Tokuyasu H; Masui K; Negayama K; Ueda N; Ishimaru M; Nakanishi Y; Fujita M; Honda J; Kadota J; Hiramatsu K; Aoki Y; Nagasawa Z; Suga M; Muranaka H; Yanagihara K; Fujita J; Tateyama M; Sunakawa K; Totsuka K
    J Infect Chemother; 2009 Jun; 15(3):156-67. PubMed ID: 19554400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nationwide surveillance of bacterial respiratory pathogens conducted by the Surveillance Committee of Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Clinical Microbiology in 2009: general view of the pathogens' antibacterial susceptibility.
    Watanabe A; Yanagihara K; Matsumoto T; Kohno S; Aoki N; Oguri T; Sato J; Muratani T; Yagisawa M; Ogasawara K; Koashi N; Kozuki T; Komoto A; Takahashi Y; Tsuji T; Terada M; Nakanishi K; Hattori R; Hirako Y; Maruo A; Minamitani S; Morita K; Wakamura T; Sunakawa K; Hanaki H; Ohsaki Y; Honda Y; Sasaoka S; Takeda H; Ikeda H; Sugai A; Miki M; Nakanowatari S; Takahashi H; Utagawa M; Kobayashi N; Takasaki J; Konosaki H; Aoki Y; Shoji M; Goto H; Saraya T; Kurai D; Okazaki M; Kobayashi Y; Katono Y; Kawana A; Saionji K; Miyazawa N; Sato Y; Watanuki Y; Kudo M; Ehara S; Tsukada H; Imai Y; Watabe N; Aso S; Honma Y; Mikamo H; Yamagishi Y; Takesue Y; Wada Y; Nakamura T; Mitsuno N; Mikasa K; Kasahara K; Uno K; Sano R; Miyashita N; Kurokawa Y; Takaya M; Kuwabara M; Watanabe Y; Doi M; Shimizu S; Negayama K; Kadota J; Hiramatsu K; Morinaga Y; Honda J; Fujita M; Iwata S; Iwamoto A; Ezaki T; Onodera S; Kusachi S; Tateda K; Tanaka M; Totsuka K; Niki Y; Matsumoto T
    J Infect Chemother; 2012 Oct; 18(5):609-20. PubMed ID: 22766652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1995). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Takanashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Kosakai N; Yamaguchi K; Matsumoto T; Kashitani F; Tanaka M
    Jpn J Antibiot; 1997 Mar; 50(3):219-50. PubMed ID: 9575353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial.
    Zhang Z; Chen M; Yu Y; Pan S; Liu Y
    Antimicrob Resist Infect Control; 2018; 7():152. PubMed ID: 30564308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Nationwide sensitivity surveillance of ciprofloxacin and various parenteral antibiotics against bacteria isolated from patients with severe infections--the first Ciproxan IV special investigation in 2001].
    Yamaguchi K; Ishii Y; Iinuma Y; Yamanaka K; Ichiyama S; Watanabe N; Uehara N; Kaku M; Kurokawa Y; Hayashi M; Hirakata Y
    Jpn J Antibiot; 2003 Dec; 56(6):546-73. PubMed ID: 15007872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the study for monitoring antimicrobial resistance trends (SMART) program: 2009-2011.
    Bouchillon SK; Badal RE; Hoban DJ; Hawser SP
    Clin Ther; 2013 Jun; 35(6):872-7. PubMed ID: 23623624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antimicrobial susceptibility and prevalence of beta-lactamase producing clinical isolates in southern Kyushu. The results of collaborative study from 1999 to 2000].
    Nakasone I; Onaga S; Fukunaga H; Saitoh H; Yamane N; Sato Y
    Jpn J Antibiot; 2002 Sep; 55 Suppl A():95-110. PubMed ID: 12599533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2000). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Fujime M; Fujita K; Hirose T; Matsukawa M; Takahashi S; Kunishima Y; Igari J; Ogihara M; Ishibashi K; Oguri T; Shigeta S; Yamaguchi K; Matsumoto T; Kashitani F; Yoshida H; Imafuku Y; Murai M; Ooe H; Nishikawa M; Watanabe K; Kobayashi Y; Uchida H; Oka T; Kitamura M; Takano Y; Matsuoka Y; Matsuda S; Sato S; Furuhama T; Kumon H; Monden K; Aoki S; Mochida C; Hirakata Y; Kohno S; Miyazaki Y; Tomono K
    Jpn J Antibiot; 2002 Aug; 55(4):370-98. PubMed ID: 12378869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2003). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Matsukawa M; Kunishima Y; Watanabe K; Kobayashi Y; Uchida H; Matsuda S; Hirose T; Sato S; Shigeta S; Fujime M; Fujita K; Yamaguti O; Ishibashi K; Igari J; Suzutani T; Oguri T; Yoshida H; Imafuku Y; Yamaguchi K; Furuya N; Murai M; Deguchi T; Ishihara S; Ooe H; Matsumoto T; Takahashi K; Nishikawa M; Naito S; Egashira T; Konishi T; Oka T; Kitamura M; Kohno S; Fukuhara Y; Hirakata Y; Kondo A; Matsuda J; Nakano M; Kamidono S; Suzuki Y; Arakawa S; Kumon H; Monden K
    Jpn J Antibiot; 2005 Dec; 58(6):518-43. PubMed ID: 16521344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2012: General view of the pathogens' antibacterial susceptibility.
    Yanagihara K; Watanabe A; Aoki N; Matsumoto T; Yoshida M; Sato J; Wakamura T; Sunakawa K; Kadota J; Kiyota H; Iwata S; Kaku M; Hanaki H; Ohsaki Y; Fujiuchi S; Takahashi M; Takeuchi K; Takeda H; Ikeda H; Miki M; Nakanowatari S; Takahashi H; Utagawa M; Nishiya H; Kawakami S; Morino E; Takasaki J; Mezaki K; Chonabayashi N; Tanaka C; Sugiura H; Goto H; Saraya T; Kurai D; Katono Y; Inose R; Niki Y; Takuma T; Kudo M; Ehara S; Sato Y; Tsukada H; Watabe N; Honma Y; Mikamo H; Yamagishi Y; Nakamura A; Ohashi M; Seki M; Hamaguchi S; Toyokawa M; Fujikawa Y; Mitsuno N; Ukimura A; Miyara T; Nakamura T; Mikasa K; Kasahara K; Ui K; Fukuda S; Nakamura A; Morimura M; Yamashita M; Takesue Y; Wada Y; Sugimoto K; Kusano N; Nose M; Mihara E; Kuwabara M; Doi M; Watanabe Y; Tokuyasu H; Hino S; Negayama K; Mukae H; Kawanami T; Ota T; Fujita M; Honda J; Hiramatsu K; Aoki Y; Fukuoka M; Magarifuchi H; Nagasawa Z; Kaku N; Fujita J; Higa F; Tateyama M
    J Infect Chemother; 2017 Sep; 23(9):587-597. PubMed ID: 28669567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1991). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Oct; 48(10):1394-421. PubMed ID: 8544337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. in Korea: 2003 KONSAR surveillance.
    Lee K; Park KH; Jeong SH; Lim HS; Shin JH; Yong D; Ha GY; Chong Y; KONSAR group
    Yonsei Med J; 2006 Feb; 47(1):43-54. PubMed ID: 16502484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2002). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Matsukawa M; Kunishima Y; Hirose T; Yamaguti O; Ishibashi K; Shigeta S; Suzutani T; Yoshida H; Imafuku Y; Murai M; Watanabe K; Kobayashi Y; Uchida H; Matsuda S; Sato S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Furuya N; Deguchi T; Ishihara S; Ooe H; Nishikawa M; Oka T; Kitamura M; Fukuhara Y; Kamidono S; Arakawa S; Kumon H; Monden K; Matsumoto T; Takahashi K; Naito S; Egashira T; Kohno S; Miyazaki Y; Hirakata Y; Aoki S
    Jpn J Antibiot; 2004 Jun; 57(3):246-74. PubMed ID: 15376785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antimicrobial susceptibilities of organisms isolated from patients with urinary tract infections in 2002].
    Eta S; Kawahara M
    Jpn J Antibiot; 2006 Feb; 59(1):21-8. PubMed ID: 16673579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.